In Episode 5 of The Biotech Pulse, Silva Dezelan, Head of Impact and ESG at Forbion, introduces a fireside chat from our 2023 AGM. The discussion, moderated by Charis Grasser, includes Forbion General Partner Alexander Hoffmann, Forbion Advisor & former CEO DSM Feike Sijbesma, and CSO Mosa Meat Mark Post, all of whom explore biotech's role in sustainability. The panel focuses on innovations in agtech, environmental tech, and food tech, including cultivated meat and sustainable energy solutions. The discussion highlights Forbion’s Bioeconomy Fund, which aims to invest in biotech companies that develop sustainable alternatives to current products. The episode underscores the importance of embedding ESG and impact into investment processes.

In Episode 5 of The Biotech Pulse, Silva Dezelan, Head of Impact and ESG at Forbion, introduces a fireside chat from our 2023 AGM. The discussion, moderated by Charis Grasser, includes Forbion General Partner Alexander Hoffmann, Forbion Advisor &amp; former CEO DSM Feike Sijbesma, and CSO Mosa Meat Mark Post, all of whom explore biotech's role in sustainability. The panel focuses on innovations in agtech, environmental tech, and food tech, including cultivated meat and sustainable energy solutions. The discussion highlights Forbion’s Bioeconomy Fund, which aims to invest in biotech companies that develop sustainable alternatives to current products. The episode underscores the importance of embedding ESG and impact into investment processes.

The Biotech Pulse is a Forbion podcast. Forbion is a leading Life Sciences venture capital firm founded in the Netherlands. Forbion helps companies bridge research and development through its team's expertise in drug development and company building. For over 15 years, Forbion has invested in over 100 companies backing exciting therapies that have the potential to impact the future of medicine. The Biotech Pulse is a forum where we speak about all things biotech with diverse stakeholders in the life sciences industry.

The Biotech Pulse is a Forbion podcast. Forbion is a leading Life Sciences venture capital firm founded in the Netherlands. Forbion helps companies bridge research and development through its team's expertise in drug development and company building. For over 15 years, Forbion has invested in over 100 companies backing exciting therapies that have the potential to impact the future of medicine. The Biotech Pulse is a forum where we speak about all things biotech with diverse stakeholders in the life sciences industry.

The Biotech Pulse

Forbion is a leading life sciences venture capital firm founded in The Netherlands, helping companies bridge research and development through our team’s expertise in drug development and company building. Over the course of 15 years we have invested in over 100 companies, backing exciting therapies that that we believe have the potential to impact the future of medicine. “The Biotech Pulse” is a forum where we speak about all things biotech with diverse stakeholders in the life sciences industry.

Forbion is a leading life sciences venture capital firm founded in The Netherlands, helping companies bridge research and development through our team’s expertise in drug development and company building. Over the course of 15 years we have invested in over 100 companies, backing exciting therapies that that we believe have the potential to impact the future of medicine. “The Biotech Pulse” is a forum where we speak about all things biotech with diverse stakeholders in the life sciences industry.